DK1942895T3 - Kombinationslægemiddel indeholdende probucol og et tetrazolylalkoxy-dihydrocarbostyrilderivat med superoxidhæmmende virkninger - Google Patents
Kombinationslægemiddel indeholdende probucol og et tetrazolylalkoxy-dihydrocarbostyrilderivat med superoxidhæmmende virkningerInfo
- Publication number
- DK1942895T3 DK1942895T3 DK06810355.5T DK06810355T DK1942895T3 DK 1942895 T3 DK1942895 T3 DK 1942895T3 DK 06810355 T DK06810355 T DK 06810355T DK 1942895 T3 DK1942895 T3 DK 1942895T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibitory effects
- drug containing
- combination drug
- dihydrocarbostyril derivative
- superoxide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71695405P | 2005-09-15 | 2005-09-15 | |
US76177506P | 2006-01-25 | 2006-01-25 | |
PCT/JP2006/318675 WO2007032557A1 (en) | 2005-09-15 | 2006-09-14 | Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1942895T3 true DK1942895T3 (da) | 2012-03-05 |
Family
ID=37420867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06810355.5T DK1942895T3 (da) | 2005-09-15 | 2006-09-14 | Kombinationslægemiddel indeholdende probucol og et tetrazolylalkoxy-dihydrocarbostyrilderivat med superoxidhæmmende virkninger |
Country Status (21)
Country | Link |
---|---|
US (2) | US8580818B2 (da) |
EP (2) | EP1942895B1 (da) |
JP (2) | JP5179354B2 (da) |
KR (1) | KR101299320B1 (da) |
AR (1) | AR057520A1 (da) |
AU (1) | AU2006289752B2 (da) |
BR (1) | BRPI0616223A2 (da) |
CA (1) | CA2620296C (da) |
CY (1) | CY1112716T1 (da) |
DK (1) | DK1942895T3 (da) |
ES (1) | ES2378896T3 (da) |
HK (1) | HK1122996A1 (da) |
IL (1) | IL189751A0 (da) |
MY (1) | MY145787A (da) |
NO (1) | NO20081811L (da) |
PL (1) | PL1942895T3 (da) |
PT (1) | PT1942895E (da) |
RU (1) | RU2411945C2 (da) |
SG (1) | SG165379A1 (da) |
TW (1) | TWI372053B (da) |
WO (1) | WO2007032557A1 (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR065588A1 (es) * | 2007-03-09 | 2009-06-17 | Otsuka Pharma Co Ltd | Un medicamento para tratar enfermedad pulmonar obstructiva cronica |
AR070816A1 (es) * | 2008-03-14 | 2010-05-05 | Otsuka Pharma Co Ltd | Farmaco de combinacion para tratar trastornos vasculares |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5535019A (en) | 1978-09-01 | 1980-03-11 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
JPH04193836A (ja) | 1990-11-26 | 1992-07-13 | Banyu Pharmaceut Co Ltd | 抗高脂血症剤 |
JPH107590A (ja) | 1996-06-24 | 1998-01-13 | Chugai Pharmaceut Co Ltd | 脳循環障害後遺症または脳虚血後の脳神経障害の治療剤 |
FR2751540B1 (fr) | 1996-07-26 | 1998-10-16 | Sanofi Sa | Composition pharmaceutique antithrombotique |
EP0946178A4 (en) | 1996-09-18 | 2003-05-07 | Merck & Co Inc | COMBINATION THERAPY TO REDUCE THE RISKS OF HEART CIRCULAR DISEASES |
US6245797B1 (en) | 1997-10-22 | 2001-06-12 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease |
AU1387399A (en) * | 1997-11-10 | 1999-05-31 | Vyrex Corporation | Probucol esters and uses thereof |
US6235311B1 (en) | 1998-03-18 | 2001-05-22 | Bristol-Myers Squibb Company | Pharmaceutical composition containing a combination of a statin and aspirin and method |
WO2000021507A2 (de) | 1998-10-12 | 2000-04-20 | Andreas Bockelmann | Pharmazeutisch wirksame zusammensetzung |
ATE326240T2 (de) | 2000-04-10 | 2006-06-15 | Nicholas John Wald | Zusammensetzung zur prävention kardiovaskulärer erkrankungen |
US20020115728A1 (en) | 2000-09-05 | 2002-08-22 | Roland Stocker | Compositions and methods for treating cardiovascular disorders |
CZ20032031A3 (cs) * | 2001-01-26 | 2003-12-17 | Schering Corporation | Farmaceutický prostředek |
US6576256B2 (en) | 2001-08-28 | 2003-06-10 | The Brigham And Women's Hospital, Inc. | Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
JP2003192573A (ja) * | 2001-12-25 | 2003-07-09 | Otsuka Pharmaceut Factory Inc | 経口ゲル製剤 |
US20030181461A1 (en) | 2002-01-25 | 2003-09-25 | Lautt Wilfred Wayne | Use of phosphodiesterase antagonists to treat insulin resistance |
US6743806B2 (en) | 2002-10-23 | 2004-06-01 | Otsuka Pharmaceutical Company, Limited | Active oxygen scavenger |
JP2005232059A (ja) | 2004-02-18 | 2005-09-02 | Iichiro Shimomura | 低アディポネクチン血症予防・治療剤 |
CN101193656B (zh) | 2005-06-08 | 2011-03-02 | 兴和株式会社 | 甘油三酸酯降低剂 |
JP4193836B2 (ja) | 2005-10-24 | 2008-12-10 | ブラザー工業株式会社 | インク噴射装置の製造方法 |
-
2006
- 2006-09-14 BR BRPI0616223-1A patent/BRPI0616223A2/pt not_active IP Right Cessation
- 2006-09-14 EP EP06810355A patent/EP1942895B1/en not_active Not-in-force
- 2006-09-14 DK DK06810355.5T patent/DK1942895T3/da active
- 2006-09-14 AU AU2006289752A patent/AU2006289752B2/en not_active Ceased
- 2006-09-14 KR KR1020087008859A patent/KR101299320B1/ko not_active IP Right Cessation
- 2006-09-14 SG SG201006668-6A patent/SG165379A1/en unknown
- 2006-09-14 PT PT06810355T patent/PT1942895E/pt unknown
- 2006-09-14 RU RU2008114512/15A patent/RU2411945C2/ru not_active IP Right Cessation
- 2006-09-14 TW TW095134039A patent/TWI372053B/zh not_active IP Right Cessation
- 2006-09-14 CA CA2620296A patent/CA2620296C/en not_active Expired - Fee Related
- 2006-09-14 MY MYPI20080610A patent/MY145787A/en unknown
- 2006-09-14 JP JP2008514987A patent/JP5179354B2/ja not_active Expired - Fee Related
- 2006-09-14 US US12/065,619 patent/US8580818B2/en not_active Expired - Fee Related
- 2006-09-14 EP EP10177619A patent/EP2275106A1/en not_active Withdrawn
- 2006-09-14 PL PL06810355T patent/PL1942895T3/pl unknown
- 2006-09-14 ES ES06810355T patent/ES2378896T3/es active Active
- 2006-09-14 AR ARP060104020A patent/AR057520A1/es unknown
- 2006-09-14 WO PCT/JP2006/318675 patent/WO2007032557A1/en active Application Filing
-
2008
- 2008-02-25 IL IL189751A patent/IL189751A0/en unknown
- 2008-04-14 NO NO20081811A patent/NO20081811L/no not_active Application Discontinuation
-
2009
- 2009-01-09 HK HK09100257.9A patent/HK1122996A1/xx not_active IP Right Cessation
-
2012
- 2012-04-20 CY CY20121100376T patent/CY1112716T1/el unknown
- 2012-09-11 JP JP2012199804A patent/JP5603393B2/ja not_active Expired - Fee Related
-
2013
- 2013-10-21 US US14/059,368 patent/US20140045889A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2006289752A1 (en) | 2007-03-22 |
HK1122996A1 (en) | 2009-06-05 |
CY1112716T1 (el) | 2016-02-10 |
SG165379A1 (en) | 2010-10-28 |
PT1942895E (pt) | 2012-03-29 |
EP1942895B1 (en) | 2012-02-01 |
ES2378896T3 (es) | 2012-04-18 |
TW200744597A (en) | 2007-12-16 |
PL1942895T3 (pl) | 2012-07-31 |
BRPI0616223A2 (pt) | 2011-06-14 |
AR057520A1 (es) | 2007-12-05 |
CA2620296C (en) | 2013-10-22 |
IL189751A0 (en) | 2008-12-29 |
JP2013014605A (ja) | 2013-01-24 |
MY145787A (en) | 2012-04-30 |
AU2006289752B2 (en) | 2011-06-09 |
CA2620296A1 (en) | 2007-03-22 |
US20090176826A1 (en) | 2009-07-09 |
EP1942895A1 (en) | 2008-07-16 |
JP5179354B2 (ja) | 2013-04-10 |
KR20080049822A (ko) | 2008-06-04 |
RU2008114512A (ru) | 2009-10-20 |
US8580818B2 (en) | 2013-11-12 |
KR101299320B1 (ko) | 2013-09-03 |
NO20081811L (no) | 2008-04-14 |
JP5603393B2 (ja) | 2014-10-08 |
WO2007032557A1 (en) | 2007-03-22 |
US20140045889A1 (en) | 2014-02-13 |
EP2275106A1 (en) | 2011-01-19 |
JP2009508804A (ja) | 2009-03-05 |
TWI372053B (en) | 2012-09-11 |
RU2411945C2 (ru) | 2011-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081604L (no) | Nitrogeninneholdende heterocyklisk forbindelse og farmasøytisk anvendelse derav | |
DK1894567T3 (da) | Ledsagende farmaceutiske midler og anvendelse deraf | |
DK2079485T3 (da) | Phenylpropionamidforbindelser og anvendelsen deraf | |
DK2081955T3 (da) | Metastinderivater og anvendelse deraf | |
DK2001556T3 (da) | Thioninium-forbindelser og anvendelse deraf | |
DE602007001088D1 (de) | Tintenpatrone und Aufzeichnungsvorrichtung | |
DK2957312T3 (da) | Inhaleringsindretning | |
DK1885716T3 (da) | Thiazolderivater og anvendelse deraf | |
HK1118829A1 (en) | Thiazole derivatives and use thereof | |
DE602006009589D1 (de) | Treibkette und Antriebsvorrichtung | |
DE602006004713D1 (de) | Trifluormethylbenzamidderivate und therapeutische verwendungen dafür | |
DK2022735T3 (da) | Overføringsapparat og overføringsgenstands-inspektionsapparat | |
DK2158199T3 (da) | Piperidinforbindelser og anvendelser deraf | |
GB0516069D0 (en) | Pharmaceutical and use thereof | |
ITMI20061766A1 (it) | Prepolimeri silano-terminati e relativi formulati adesivo-sigillanti | |
EP2077262A4 (en) | IMINOPYRIDINE DERIVATIVES AND THEIR USE | |
EP2111226A4 (en) | CYCLITOES AND THEIR DERIVATIVES AND THERAPEUTIC APPLICATIONS THEREOF | |
DE602006002678D1 (de) | Treibkette und Treibvorrichtung | |
DK2029561T3 (da) | Tricyclisk forbindelse og farmaceutisk anvendelse deraf | |
DE112006002272T8 (de) | Katheter und Katheter-Kit | |
DE112007001250A5 (de) | Planarer Direktantrieb und dazugehörige Sensoreinheit | |
AT508430A5 (de) | Formbauteil und dessen verwendung | |
DK1954288T3 (da) | Amidin-derivater og anvendelse deraf som lægemiddel | |
DK1942895T3 (da) | Kombinationslægemiddel indeholdende probucol og et tetrazolylalkoxy-dihydrocarbostyrilderivat med superoxidhæmmende virkninger | |
DK1976853T3 (da) | Nye forbindelser og anvendelse heraf |